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1. Introduction 
It is generally agreed that one of the most stringent 
requirements for the interferon inducing capacity of 
polynucleotide inducers is double-strandedness [ 1 ] . 
This definition is frequently accompanied by other 
operational criteria, namely high molecular weight, 
high 7’, (thermal stability), resistance to nuclease 
degradation and presence of 2’-hydroxyl groups. 
Considering these criteria, one would expect many 
double-stranded RNA complexes to be equally eff- 
cient polynucleotide inducers. 
Indeed, complementary polynucleotides duplexes 
such as poly(A) . poly(U), poly(I) . poly(C) have 
quite similar helical parameters, the same sugar 
puckering [2], a sufficient high Tm and they are 
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known to have a high degree of resistance to nucleo- 
lytic degradation. Yet, only poly(1) . poly(C) behaves 
invariably as a potent inducer while poly(A) . poly(U) 
is definitely less effective. Poly(C) . poly(G) has been 
found effective by some but not by others. Strand- 
wise rearrangemerit could be proposed to explain the 
low activity of poly(A) . poly(U). However, strand- 
wise rearrangement is highly improbable under the 
ionic conditions and temperature used for interferon 
induction. Phase diagram of the poly(A) - poly(U) 
[3] and poly(1) - poly(C) [4] complexes clearly show 
that, in the domain considered, only double-stranded 
complexes occur, provided one starts with an equi- 
molar mixture of complementary polynucleotides. 
In recent studies [5,6] the double-stranded com- 
plexes poly(c’A) . poly(U), poly(c’A) . poly(rT), 
poly(c’A) . poly(br’U), poly(L) . poly(C) and 
poly(L) . poly(br’C) were found to be inactive in 
interferon induction, although these complexes Partly 
or completely fulfilled the criteria mentioned above. 
A very recent investigation [7] of the conformation 
of polynucleotides and polynucleotide analogs con- 
cluded that interferon induction is dependent on the 
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recognition of a particular spatial and steric organiza- 
tion of a double-stranded RNA. On the other hand, 
it was reported that ‘single-stranded’ polynucleotides, 
in particular poly(I), could, in some conditions, elicit 
an interferon response [8,9]. Other reports (see 
Discussion) have emphasized the importance of the 
poly(1) strand in the poly(1) e poly(C) complex. What 
structural feature the interferon inducing ability 
of polynucleotide precisely depends on, has not been 
established. 
In this paper, we describe the properties of two 
poly(1) preparations which demonstrated an unusually 
high interferon inducing activity both in vitro (cell 
cultures) and in vivo (animals). 
Methods 
2.1. Polynucleotide synthesis 
Polynucleotides poly(I), poly(C), poly(A), poly(U) 
and p01y(‘~C) were synthesized by agarose-bound 
purified Escherichia coli polynucleotide phosphorylase 
(agarose-PNPase) as described previously [lo] . The 
enzyme was prepared by a modified procedure 
described previously [ 111. 
All batches of poly(1) synthetized in the laboratory 
were pepared with the same batch of IDP. Poly(1) 
09,lO and 11 were the products of the first, second 
and third cycle of polymerization catalyzed by the 
same agarose-PNPase. Poly(1) CVl and CV2 were 
the products of the first and second cycle of poly- 
merization catalyzed by another batch of agarose- 
PNPase. Poly(1) 315,332 and 338, synthesized by 
the same methods, were provided by Choay Labora- 
tories, Paris, France. Other polynucleotides were 
purchased from various commercial sources: Miles 
Laboratories Elkhart, Indiana, P-L Biochemicals 
Milwaukee, Wisconsin, Choay Laboratories Paris, 
France, Mycophage dsRNA (Penicillium BRL-5907) 
was obtained from D. N. Planterose, Beecham Research 
Laboratories Betchworth, Surrey, England. Bacterio- 
phage f2 dsRNA was supplied by Dr L. Borecky, 
Institute of Virology, Slovak Academy of Sciences, 
Bratislava, Czechoslovakia. 
2.2. Serological analyses 
Rabbit antibodies specific for double-stranded RNA 
were induced by poly(A) . poly(U)-methylated BSA 
complexes [ 121 and immuno-specifically purified 
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from precipitates made with poly(1) . poly(C) [ 131. 
Anti-poly(1) antiserum was obtained by similar 
immunization of rabbits with commercial poly(1) 
(P-L Biochemicals). Quantitative micro-complement 
fixation assays were performed as described elsewhere 
[141* 
2.3. Interferon induction 
Interferon induction in PRK (primary rabbit kidney 
cells) was measured as described previously [S] . 
2.4. Nucleoside diphosphates 
Nucleoside diphosphates IDP, CDP, ADP, UDP, 
GDP were purchased from Yamasa, Shoyu, Japan. 
The purety of IDP was controlled in the laboratory 
by paper chromatography and PEI-cellulose thin- 
layer chromatography [ 1 S] . No contaminant nucleo- 
side diphosphates were detected. 
3. Results 
3.1. Interferon induction in PRK cells 
In several experiments carried out in PRK cells 
over a more than 2-year period, poly(1) 09 and CV2 
reproducibly exhibited about one-third of the inter- 
feron inducing capacity of poly(1) - poly(C) (table 1). 
Table 1 
Comparative interferon inducing activity of different 
polymers in PRK cells superinduced with cycloheximide and 
actinomycin D 
Polymersa Interferon titerb (U/ml) 
Poly(1) 09 2100 (lOOO- 6000) 
Poly(I) 10 < 10 
Poly(I) 11 < 10 
Poly(1) CVl =G 10 
Poly(1) cv2 2600 (2000- 6000) 
Poly(1) 315 < 10 
Poly(1) 332 < 10 
Poly(1) 338 < 10 
Poly(1) P-L Q 10 
Po~Y(N . PO~YW) 1000 (300- 3000) 
POlYU) . POlYc-3 7100 (3000-20 000) 
Mycophage (Penicillium) dsRNA 110 (60- 200) 
Bacteriophage (f2) dsRNA 120 (30- 200) 
a All polymers were assayed at 10 &ml 
b Mean values (in parentheses, range of individual results) 
for at least 12 observations (only 3 for mycophage dsRNA 
and bacteriophage dsRNA) 
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Effect of different treatments on interferon inducing activity of poly(1) 09 in 
PRK cells superinduced with cycloheximide and actinomycin D 
Treatmenta Interferon titer (U/ml) 
Untreated 3000 (1000-6000) 
Dialyzed 3000 
Heated at 60°C for 5 min, then cooled 3000 
Filtered through millipore (0.025 PM) 3000 
Treated with RNAase T, < 10 
Poly(1) . poly(C) P-L 10 000 
Poly(I) . poly(C) P-L, treated with 
RNAase T, 6000 
a Poly(I) 09 was first diluted to 10 &ml in Eagle’s minimal essential medium 
(MEM), treated as indicated and then tested for interferon induction. When treated 
with RNAase T,, the polymers were first diluted to 10 &ml in MEM + 1 mM 
EDTA containing 0.1 )&ml RNAase T,, incubated for 1 h at 37°C and then 
applied onto the cells. 
Both preparations were slightly but consistently more 
active than poly(A) - poly(U). They were significantly 
more effective than bacteriophage and mycophage 
dsRNA. Other poly(1) preparations (IO, 11, CVl , 
315,332,338 and P-L) were devoid of any interferon 
inducing activity (table 1). However, all poly(1) 
samples gained full interferon inducing activity when 
poly(C) was added to form poly(I) - poly(C). 
Neither dialysis nor heating followed by rapid 
cooling affected the interferon inducing capacity of 
poly(1) (table 2). No loss of activity was noted upon 
filtration of poly(1) through millipore (pore size 
25 nm), suggesting that an aggregated form of poly(1) 
such as that described by Maurizot and Boubault [ 171 
was not responsible for the activity. Treatment with 
RNAase Tr abolished the interferon inducing activity 
of poly(1). 
The two poly(1) preparations which were active in 
PRK cells have also been shown to induce interferon 
in various other assay systems: e.g., mouse L cells 
(in vitro) and rabbits (in vivo) (De Clercq et al., 
manuscript in preparation). 
3.2. Chemical purity of poly(I) 
The fact that nearly homogenous E. coli PNPase, 
covalently bound to solid support, was used for the 
synthesis of poly(I) excluded virtually any protein 
contaminants originating from the enzyme prepara- 
tion. The enzyme/nucleotide ratio (w/w) was approxi- 
mately l/lo4 and there was no significant loss of 
enzymatic activity after several cycles of polymeriza- 
tion. 
The final product poly(1) did not contain any 
nucleotide other than IMP, as assessed by the follow- 
ing criteria. Paper chromatography or PEI-cellulose 
thin-layer chromatography of the alkaline hydrolyzate 
of poly(1) showed the presence of IMP only, even 
when 12 A2m units of hydrolysis was applied. When 
the product of complete phosphorolysis of poly(1) 
catalyzed by polynucleotide phosphorylase in the 
presence of highly radioactive [“‘PI orthophosphate 
was analysed by the same methods, one found only 
32 [P]IDP. The sensitivity of this technique permitted 
to ascertain that the purity of poly(1) was greater 
than 99.5%. 
No detectable divalent ions such as Mg2*, Mn2+ or 
Ca2+ were found in poly(1) samples by atomic absorp- 
tion spectroscopy. 
3.3. Physical properties 
All batches poly(I), inducers or not, had the known 
ultraviolet spectra and CD-spectra. Even when the 
CDspectra were recorded by raising rapidly the ionic 
strength to detect the cryoform of poly(I) [ 181, using 
two couples of inducer-non-inducer, namely poly(1) 
CV2 and 338 and poly(I) 09 and 10, no significant 
difference could be observed between an interferon 
inducer poly(I) and a non-inducer poly(1) (fig. la,b; 
161 
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I ’ ’ ’ I spectra on poly(I) 09 and 10 are not shown). This 
B 
10 indicated that the poly(1) samples examined could be 
338 considered as identical as far as their overall structure 
is concerned. However, conformational heterogeneity 
has been observed among many poly(1) samples 
(see below). Further evidence for a structural similarity 
was provided by studies on complex formation 
between poly(C) and poly(I), poly(A) and poly(I), 
and poly(A) - poly(u) and poly(1). The mixing curves 
obtained comparatively for poly(1) 09 and poly(1) 10 
Xl (@.2a,b,c) clearly pointed to a similarity of their 
structural features. 
I I I * I 1 
3 2M) 3DOnm The T,, measured in 1 M NaCl [ 181, of most 
poly(1) samples including the interferon inducer 
Fig.1. CD-Spectra of poly(I) as a function of ionic strength: 
(A) poly(I) CV2, (B) poly(1) 338 (--) in water, (- - - -) 
recorded 1 h after addition of NaCl to 1 .O M. 
poly(1) CV2 and the non-inducer poly(1) CVI , was 
PP0ly I 
40 20 4[+ 
b C 
a9 
0.7 
‘3, “C Poly c %Poly I 
Fig.2. Complex formation between poly(1) and complementary polynucleotide: (A) inducer poly(1) 09, (B) non-inducer poly(1) 
10. (a) Poly(1) and poly(C). Poly(1) was mixed with poly(r4C) in 6 mM phosphate buffer pH 7, containing 1.5 mM NaCl and 
equilibrated at 4°C for 20 h. Pancreatic RNAase (from Worthington) was added at a concentration of 1 &ml and the mixture 
was incubated at 20°C for 90 s. The polynucleotides were then precipitated with HClO, 5% (v/v). The radioactivity in the super- 
natant corresponded to unpaired p01y(‘~C) degraded by RNAase (o-o) and the cpm in the washed precipitate to that of the 
poly(1) . poly(i4C) complex. (b) Poly(1) and poly(A). Poly(1) was mixed with poly(A) in 10 mM sodium cacodylate pH 7 con- 
taining 0.09 M NaCl and equilibrated at 4°C for 20 h. Complex formation was measured at 244 nm, 254 nm and 258 nm. (c) 
Poly(1) and poly(A) . poly(U). Poly(A) . poly(U) was previously formed under standard conditions. Poly(A) . poly(U) was then 
mixed with poly(1) as in (b). Triplex formation was monitored at 250 nm and 255 nm. 
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Fig.3. Complement fixation of varying quantities of inducer 
and non-inducer poly(1) with immunospecitically purified 
antibodies to double-stranded RNA (final dilution l/300). 
around 42°C although one non-inducer [poly(I) 3381 
had a rrn = 45°C. 
3.4. Reactions with antibodies 
Significant differences were observed in the recog- 
nition of our poly(I) samples by antibodies to either 
double-stranded RNA or to poly(1). The inducer 
poly(I) CV2 and 09 did react with antibodies to 
double-stranded RNA, while non-inducer samples did 
not (tig.3). Much more poly(1) CV2 than the standard 
polY(I) * polY(C) was required for a given level of 
complement fixation. Even higher concentrations of
poly(1) 09 than that of poly(1) CV2 was needed for 
a significant complement fixation. The meaning of 
these differences will be discussed in a next communi- 
cation (B. D. Stollar et al., manuscript in prepara- 
tion). From a comparison of these amounts, it appeared 
that about 1.5% of the poly(1) CV2 reacted as if it 
were double-stranded. In view of the high interferon 
inducicg activity of this material, this result raised 
the question of whether only 1.5% of the molecules 
of the poly(1) are particularly efficient in induction 
while most of the structure is identical with non- 
inducer poly(I), or whether the whole poly(1) CV2 
population has a different structure, with some local 
regions of helical configuration appropriate for these 
antibodies. 
Experiments with anti-poly(1) antibodies indicated 
that, in fact, a large part of the poly(I) CV2 popula- 
tion differed from non-inducer samples. In comple- 
ment fixation assays, non-inducer poly(1) preparations 
gave SO-90% complement fixation with a l/3000 
final serum dilution, while poly(1) CV2 required 
four-times as much serum to give even 30-50% com- 
plement fmation. For further exploration of this 
question, the IgG fraction of anti-poly(1) antiserum 
was prepared and covalently linked to Sepharose 4B 
to provide an affinity column. The column was 
specific for poly(1) and did not bind any of 
poly(A) * PO~YW, PO~YU) . POSY, poly(A), yeast 
RNA or native or denatured DNA. A column that 
was able to bind most of a sample of non-inducer 
poly(I) bound only 20% of a similar sample of 
poly(1) CV2. Even the bound portion in the latter 
case was weakly retained, since half of it could 
be washed off with PBS; only a much smaller frac- 
tion of the bound non-inducer poly(1) was washed 
off with PBS. These results eliminate the possibility 
that the activity of poly(1) CV2 was due to a 1 .S% 
content of double-stranded molecules in a population 
otherwise identical with the non-inducers. Details 
of these experiments will be published elsewhere. 
4. Discussion 
The structure of poly(1) remains badly understood. 
It is assumed [18] that this polynucleotide is a 
single-stranded, rather poorly stacked helix at low 
ionic strength. At higher salt concentrations (> 0.1 M 
NaCl), its structure depends on the ionic strength, 
the divalent ions, the temperature and the time 
factor. In PBS buffer and MEM medium, at least part 
of the poly(1) should be multi-stranded. 
To the best of our knowledge with regard to the 
mode of action of E. coli polynucleotide phosphorylase, 
it is not conceivable that poIy(1) samples, prepared 
under identical conditions with an unique batch of 
IDP could have an overall structure different from 
one preparation to another. However, we did find 
conformational heterogeneity among poly(1) prepara- 
tions, as defined by their interaction with anti-dsRNA 
antibodies (Stollar et al., in preparation). 
It may be assumed therefore that the particular 
structural element in inducer poly(1) which is recog- 
nized by anti-dsRNA antibodies and by the hypo- 
thetical interferon receptor site, is introduced acci- 
dentally in poly(1) after its synthesis. A helical 
region formed by complementary base-pairing is very 
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unlikely since biochemical analysis showed more than 
99.5% purity in IMP moieties. Also, X-ray diffraction 
studies (S. Arnott) of the inducer poly(1) 09 did not 
reveal a pattern different from the usual poly(1) 
pattern. 
In the absence of a precise physico-chemical basis 
for the particularly high interferon inducing activity 
of poly(1) 09 and CV2, we tentatively suggest hat a 
portion of the poly(1) could be self-structured in a 
highly stable conformation. Such contormation may 
be introduced by local nucleation or covalent linkage 
between two bases. The bridging agent could be an 
unknown chemical agent or a photo-chemical product. 
Thus, a single-stranded poly(1) could be activated* 
and become an inducer for interferon production 
according to the following scheme: 
/ /a--- 
POlY(I) Po]Y(*I) 
non-inducer 
v 
inducer (A) 
Several reports point to a differential importance 
of poly(1) and poly(C) in the process of interferon 
induction by poly(1) . poly(C) [ 19-241. When poly(1) 
and poly(C) are administered separately to the cells, 
they reunite at the cell-surface [23]. A significantly 
greater interferon response has been obtained in cell- 
cultures exposed to poly(1) followed by poly(C) than 
in cell-cultures exposed to poly(C) followed by 
poly(I), and this increased interferon response 
appeared to be related to a firmer binding of poly(1) 
poly(C) to the cell [24]. These findings suggest hat 
in the induction of interferon by poly(1) . poly(C), 
poly(1) would play a central role. In fact, poly(C) 
may be replaced by a distantly related analog (poly( l- 
vinylcytosine)) without siginiflcant loss of (in vitro) 
activity [25]. 
Accordingly, one could extend scheme (A) to 
POlY(I) * PO]Y(Q 
POlY(I) * POlY(C) A POSY . POSY @) 
and postulate that an r1 sequence stabilized in a 
suitable conformation by a factor x tits in the recep- 
tor site of the cell membrane and initiates the process 
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of interferon production. The remaining part of the 
polynucleotide would serve for attachment. Factor x 
may be a cellular component in the case of interferon 
induction by poly(1) - poly(C), or, in the case of 
poly(1) it may be DEAE-dextran, protamine or 
neomycin [8-91 or nucleation or the hypothetic 
bridging agent. This hypothesis is now under investi- 
gation using model polynucleotides. 
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